Evidence map›Paper›PMID 30978583›Full record

ArticleAddictive behaviors2019

Longitudinal associations between smoking and affect among cancer patients using varenicline to quit smoking.

Allison J Carroll, Kristine Kim, Andrew Miele, Matthew Olonoff, Frank T Leone, Robert A Schnoll, Brian Hitsman

Open access · greenAbstract read
In one paragraph

Article in Addictive behaviors, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Systematic Review of Smoking Cessation Interventions for Smokers Diagnosed with Cancer.International journal of environmental research and public health · 2022
    Pooled it
  2. Smoking cessation for improving mental health.The Cochrane database of systematic reviews · 2021
    Pooled it
  3. A qualitative study of attitudes and perceptions of smoking cessation medication among patients with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Allison J CarrollDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
Kristine KimDepartment of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States of America.
Andrew MieleDepartment of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States of America.
Matthew OlonoffDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
Frank T LeoneDepartment of Medicine, Division of Pulmonary, Allergy, & Critical Care, University of Pennsylvania, PA, United States of America.
Robert A SchnollDepartment of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States of America.
Brian HitsmanDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America. Electronic address: b-hitsman@northwestern.edu.
University of Pennsylvania · USNorthwestern University · US

Funding

Behavioral Activation and Varenicline for Smoking Cessation in Depressed SmokersR01CA184211 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HITSMAN, BRIAN L · 2014 to 2018
$3.2M
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical TrialR01CA165001 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SCHNOLL, ROBERT ADAM · 2012 to 2016
$3.0M
A Patient-Oriented Research Mentoring Program in Tobacco Dependence ResearchK24DA045244 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI Robert Adam Schnoll · 2018 to 2026
$1.7M
NCI NIH HHS R01 CA165001NCI NIH HHS R01 CA184211NIDA NIH HHS K24 DA045244
6 · The paper itself

Abstract

During a quit attempt, high negative affect predicts relapse to smoking. In this study, we evaluated bidirectional longitudinal associations between smoking and negative affect among cancer patients treated with varenicline. Participants (N = 119, 50% female, M

Indexed as

AffectAgedCigarette SmokingFemaleHumansLongitudinal StudiesMaleMiddle AgedNeoplasmsRandomized Controlled Trials as TopicSmoking CessationSmoking Cessation AgentsVareniclineSmoking Cessation AgentsVareniclineAdherenceAffectCancerRandomized controlled trialSmoking cessation

Identifiers

PMID30978583
PMCPMC6545135
OpenAlexW2926446843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.